Genetic Technologies Limited Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
February 26 2021 - 9:20AM
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the
“Company”), a leader in the development of genetic risk assessment
tests, today announced an interview with Dr. George Muchnicki,
Chief Medical Officer and Executive Director, will air on The
RedChip Money Report® on Bloomberg TV in the US on Saturday,
February 27, at 7 p.m. local time in 73M homes across the United
States. The RedChip Money Report® also airs on Bloomberg
International in Europe in 100M homes at 6 pm local time on
Sundays.
In the exclusive interview, Dr. Muchnicki
discusses the Company’s cancer predictive testing and assessment
tools to help physicians proactively manage patient health. Also
discussed is the global market opportunity, upcoming predictive
testing milestones and the capacity for Covid-19 (SDR) serious
disease risk testing and the company’s developing pipeline of risk
assessment products including guideline driven reimbursable
Germline panel testing for cancers, heart disease and metabolic
diseases such as Type 2 Diabetes.
To view the interview segment, please visit:
https://youtu.be/D7Rk9ezrWGM
“The RedChip Money Report" delivers insightful
commentary on small-cap investing, interviews with Wall Street
analysts, financial book reviews, as well as featured interviews
with executives of public companies.
About Genetic Technologies Limited
Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) is a
diversified molecular diagnostics company. GTG offers, and soon to
be released Cardiovascular and Metabolic predictive testing and
assessment tools to help physicians proactively manage patient
health. The Company’s lead products GeneType for Breast Cancer for
non-hereditary breast cancer and GeneType for non-hereditary
Colorectal Cancers are clinically validated risk assessment tests
and are first in class.
Genetic Technologies has capacity for Covid-19 testing and is
growing its pipeline of risk assessment and stratification
products.
For more information, please
visit www.gtglabs.com.
Forward-Looking StatementsThis press release
may contain forward-looking statements about the Company’s
expectations, beliefs or intentions regarding, among other things,
statements regarding the expected use of proceeds. In addition,
from time to time, the Company or its representatives have made or
may make forward-looking statements, orally or in writing.
Forward-looking statements can be identified by the use of
forward-looking words such as “believe,” “expect,” “intend,”
“plan,” “may,” “should” or “anticipate” or their negatives or other
variations of these words or other comparable words or by the fact
that these statements do not relate strictly to historical or
current matters. These forward-looking statements may be included
in, but are not limited to, various filings made by the Company
with the U.S. Securities and Exchange Commission, press releases or
oral statements made by or with the approval of one of the
Company’s authorized executive officers. Forward-looking statements
relate to anticipated or expected events, activities, trends or
results as of the date they are made. Because forward-looking
statements relate to matters that have not yet occurred, these
statements are inherently subject to risks and uncertainties that
could cause the Company’s actual results to differ materially from
any future results expressed or implied by the forward-looking
statements. Many factors could cause the Company’s actual
activities or results to differ materially from the activities and
results anticipated in such forward-looking statements as detailed
in the Company’s filings with the Securities and Exchange
Commission and in its periodic filings in Australia and the risks
and risk factors included therein. In addition, the Company
operates in an industry sector where securities values are highly
volatile and may be influenced by economic and other factors beyond
its control. The Company does not undertake any obligation to
publicly update these forward-looking statements, whether as a
result of new information, future events or otherwise, except as
required by law.
Investor Relations and Media (US)Dave Gentry, CEORedChip
CompaniesOffice: 1 800 RED CHIP (733 2447)Cell: US 407 491
4498dave@redchip.com
Genetic Technologies (NASDAQ:GENE)
Historical Stock Chart
From Aug 2024 to Sep 2024
Genetic Technologies (NASDAQ:GENE)
Historical Stock Chart
From Sep 2023 to Sep 2024